EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Is Unidentified Cytopenia Truly Unidentified? Or Are We Overlooking Clonality?

Elcin Erdogan Yucel iD, Hale Bulbul Dilmen, Ozge Ozer Kaya, Zehra Narli Ozdemir, Merve Kakci, Bahriye Celik, Mustafa Kemal Yeniay, Fatma Keklik Karadag, Aybuke Olgun, Taha Resid Ozdemir iD, Cengiz Ceylan, Oktay Bilgir und 1 weitere

Medicina · 01.05.2026 · 62 (5) · 868

DOI: 10.3390/medicina62050868 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medicina, online erschienen am 01.05.2026. Verfasst von Elcin Erdogan Yucel und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Izmir City Hospital, University of Health Sciences, Izmir 35535, Turkey. Hauptthemen laut MEDLINE: Cytopenia, Clonal Hematopoiesis. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objectives: Peripheral cytopenia occurs in approximately 2% of the population; however, in up to 0.9%, no cause is identified by conventional tests. Next-Generation Sequencing (NGS) detects somatic variants consistent with clonal hematopoiesis (CH). We aimed to determine the prevalence of CH and pre-myelodysplastic syndrome (pre-MDS) using a 51-gene panel with histopathological assessment. Materials and Methods: Bone marrow samples from 96 consecutive patients evaluated for cytopenia were retrospectively analyzed for genetic alterations.

Results

In the overall cohort (n = 96), the median follow-up was 8.1 months (range, 1–20). A total of 37 (39%) out of 96 patients were diagnosed with idiopathic cytopenia of undetermined significance (ICUS), 9 (9%) with clonal cytopenia of undetermined significance (CCUS), 9 (9%) with clonal cytopenia and monocytosis of undetermined significance (CCMUS), 34 (36%) with myelodysplastic syndrome (MDS), and 7 (7%) with myelodysplastic/myeloproliferative neoplasm (MDS/MPN). Among 41 patients in whom no cytogenetic abnormalities were detected by fluorescence in situ hybridization (FISH), somatic variants were identified by NGS. In CCUS, 88% of patients had a single variant, most commonly ASXL1 (44%), followed by TET2 (22%). In CCMUS, ASXL1 and DNMT3A (each 25%) were the most frequent variants. The mean variant allele frequency (VAF) was higher in MDS (33.4%) than in CCUS/CCMUS (13.6%). In MDS patients aged 60 years and older, a higher number of variants were found compared to patients aged less than 60 years (p = 0.028). RUNX1 variants (n = 8) were associated with leukopenia (p = 0.012). Patients with SRSF2 variants (n = 4) had significantly poorer progression-free survival (p = 0.001). EZH2 and SETBP1 variants were associated with inferior overall survival (p = 0.04 and p = 0.019, respectively). In MDS patients (n = 34), thrombocytopenia (plt < 100.000) was associated with shorter PFS (p = 0.005).

Conclusions

Given that pre-MDS conditions are considered predictors of hematologic malignancies, conventional diagnostic workup may be insufficient to accurately identify these entities, whereas NGS provides significant additional diagnostic value.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytopeniaClonal HematopoiesisHumansRetrospective StudiesFemaleMiddle AgedAgedMaleMyelodysplastic SyndromesAged, 80 and overHigh-Throughput Nucleotide SequencingAdultDioxygenasesRepressor ProteinsDNA Methyltransferase 3ADNA-Binding ProteinsCohort StudiesProto-Oncogene Proteins

Stichwörter der Autor:innen

clonal hematopoiesiscytopeniamyelodysplastic syndromessequence analysis

Substanzen

TET2 protein, humanDioxygenasesRepressor ProteinsDNA Methyltransferase 3ADNA-Binding ProteinsASXL1 protein, humanProto-Oncogene Proteins

Autor:innen und Institutionen

  • Department of Hematology, Izmir City Hospital, University of Health Sciences, Izmir 35535, Turkey.
  • Genetic Diagnosis Center, University of Health Sciences, Izmir City Hospital, Izmir 35540, Turkey.
  • Department of Hematology, Dokuz Eylul University, Izmir 35210, Turkey.
  • Department of Hematology, Ege University, Izmir 35040, Turkey.

ORCID-Profile: Elcin Erdogan Yucel, Taha Resid Ozdemir

Zitieren

APA

Erdogan Yucel, E., Bulbul Dilmen, H., Ozer Kaya, O., Narli Ozdemir, Z., Kakci, M., Celik, B., Yeniay, M. K., Keklik Karadag, F., Olgun, A., Ozdemir, T. R., Ceylan, C., Bilgir, O., & Alacacıoğlu, İ. (2026). Is Unidentified Cytopenia Truly Unidentified? Or Are We Overlooking Clonality?. Medicina, 62(5), 868. https://doi.org/10.3390/medicina62050868

Vancouver

Erdogan Yucel E, Bulbul Dilmen H, Ozer Kaya O, Narli Ozdemir Z, Kakci M, Celik B, et al. Is Unidentified Cytopenia Truly Unidentified? Or Are We Overlooking Clonality?. Medicina. 2026;62(5):868. doi:10.3390/medicina62050868

BibTeX
@article{ErdoganYucel2026,
  author = {Erdogan Yucel, Elcin and Bulbul Dilmen, Hale and Ozer Kaya, Ozge and Narli Ozdemir, Zehra and Kakci, Merve and Celik, Bahriye and Yeniay, Mustafa Kemal and Keklik Karadag, Fatma and Olgun, Aybuke and Ozdemir, Taha Resid and Ceylan, Cengiz and Bilgir, Oktay and Alacacıoğlu, İnci},
  title = {Is Unidentified Cytopenia Truly Unidentified? Or Are We Overlooking Clonality?},
  journal = {Medicina},
  year = {2026},
  volume = {62},
  number = {5},
  pages = {868},
  doi = {10.3390/medicina62050868}
}
Kostenlos starten →